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Objectives: To assess clinical 
characteristics and treatment modalities 
in patients with small cell carcinoma of 
the cervix and the effect this has on 
overall (OS) and recurrence free 
survival (RFS). 
Methods: A retrospective chart review 
was completed for all patients treated 
for small cell carcinoma of the cervix 
between 1990-2009 among providers at 
a single institution. Demographic, 
clinicopathologic, treatment, and 
recurrence data were extracted from the 
medical record and analyzed. Cox 
proportional hazards models were used 
for the recurrence and overall survival 
analyses. Multivariable analysis was 
used for association analyses.  Specific 
interest was given to pre-operative 
imaging, chemotherapy and radiation 
regimens, and recurrence location.  
Results: 52 patients were treated for 
small cell cervical carcinoma at our 
institution from 1990-2009.  Of these, 38 
patients were analyzed, with those 
excluded due to lack of data. Among 
these patients, median RFS and OS 
were noted to be 11 months and 18 
months, respectively. Univariate 
analysis for RFS demonstrated receipt 
of PET-CT (HR=2.64), not undergoing 
radical hysterectomy-BSO (RH-BSO) 
(HR=3.20) and pelvic node dissection 
(PLND) (HR=2.65) to be associated with 
worse outcomes (p<0.01), while for OS 
advanced stage (HR=2.38) , receipt of 
PET-CT (HR=2.64), not undergoing RH-
BSO (HR=3.86) and PLND (HR=2.98), 
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presence of metastases (HR=2.50) and 
not receiving post-op chemotherapy 
(HR=2.21) to be associated with worse 
outcomes (p<0.1). Multivariate analysis 
for RFS and OS identified receipt of 
PET-CT and not receiving a RH-BSO 
and PLND to be associated with an 
increased risk of death (p<0.01).  
Conclusions: Overall and progression 
free survival were worse for patients 
who did not undergo RH-BSO.  PET-CT 
may be a better imaging modality for 
identifying distant disease in patients 
with small cell carcinoma of the cervix. 
Prospective investigation is warranted to 
better assess survival differences 
among patients who undergo any 
combination of surgery, chemotherapy, 
or radiation. 
Learning Objectives: Learners will be 
able to identify characteristics important 
in outcomes for patients with small cell 
carcinoma of the cervix. 
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